The interdisciplinary Meyer-Chabris lab (July 2017–) uses a range of methods — primarily experimental, but also other quantitative and qualitative methods — to study judgment and decision-making related to research and health care. Current areas of interest include comparative effectiveness of different approaches to informed consent; information avoidance (especially in genetic/genomic and health-related contexts); attitudes to research and other learning activities — including experimentation, biobank research, research comparing standards of care, and "sensitive" secondary research;  the effects of returning a variety of genetic and genomic information to patients and participants; attitudes towards and the effects of "nudges"; and many aspects of IRB quality, including risk-benefit analysis.​